Roshni Rao

2.1k total citations
56 papers, 1.4k citations indexed

About

Roshni Rao is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, Roshni Rao has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cancer Research, 30 papers in Oncology and 17 papers in Surgery. Recurrent topics in Roshni Rao's work include Breast Cancer Treatment Studies (40 papers), Breast Implant and Reconstruction (16 papers) and Breast Lesions and Carcinomas (13 papers). Roshni Rao is often cited by papers focused on Breast Cancer Treatment Studies (40 papers), Breast Implant and Reconstruction (16 papers) and Breast Lesions and Carcinomas (13 papers). Roshni Rao collaborates with scholars based in United States, South Korea and India. Roshni Rao's co-authors include David Euhus, Valerie Andrews, Amy Moldrem, Venetia Sarode, Charles M. Balch, Helen Mayo, Kelly K. Hunt, Gildy V. Babiera, Gabriel N. Hortobágyi and Henry M. Kuerer and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Roshni Rao

53 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roshni Rao United States	21	869	650	427	421	217	56	1.4k
Linda de Munck Netherlands	22	947 1.1×	980 1.5×	366 0.9×	470 1.1×	213 1.0×	79	1.6k
Peter Lovrics Canada	17	720 0.8×	292 0.4×	656 1.5×	451 1.1×	142 0.7×	51	1.4k
Anni Ravnsbæk Jensen Denmark	15	391 0.4×	557 0.9×	250 0.6×	220 0.5×	265 1.2×	24	1.2k
Vani Parmar India	20	782 0.9×	847 1.3×	247 0.6×	239 0.6×	342 1.6×	106	1.5k
Delray J. Schultz United States	18	877 1.0×	552 0.8×	361 0.8×	613 1.5×	245 1.1×	21	1.3k
Marie-Christine Falcou France	19	1.3k 1.5×	588 0.9×	1.3k 3.0×	745 1.8×	222 1.0×	42	2.1k
L. Weir Canada	10	753 0.9×	334 0.5×	422 1.0×	449 1.1×	136 0.6×	21	1.0k
Knud Andersen Denmark	18	1.0k 1.2×	772 1.2×	289 0.7×	500 1.2×	156 0.7×	31	1.4k
Nicole Hodgson Canada	16	393 0.5×	246 0.4×	318 0.7×	266 0.6×	195 0.9×	45	882
Lorenza Marotti Italy	10	771 0.9×	784 1.2×	246 0.6×	239 0.6×	166 0.8×	25	1.2k

Countries citing papers authored by Roshni Rao

Since Specialization

Citations

This map shows the geographic impact of Roshni Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roshni Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roshni Rao more than expected).

Fields of papers citing papers by Roshni Rao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roshni Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roshni Rao. The network helps show where Roshni Rao may publish in the future.

Co-authorship network of co-authors of Roshni Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Roshni Rao. A scholar is included among the top collaborators of Roshni Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roshni Rao. Roshni Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rao, Roshni, et al.. (2025). Incidence of Lymph Node Involvement in Clinically Node-Negative Breast Cancer Following Neoadjuvant Chemotherapy: Rationale for Selective Omission of Sentinel Lymph Node Biopsy. Clinical Breast Cancer. 25(6). 529–533.

Connelly, Courtney, et al.. (2024). Gynecologic and breast cancers with hereditary cancer predisposition syndromes. SHILAP Revista de lepidopterología. 38. 300764–300764.

Iwai, Yoshiko, et al.. (2022). Shaves off the Cavity or Specimen in Lumpectomy for Breast Cancer. Journal of Surgical Research. 277. 296–302. 1 indexed citations

Ludwig, Kandice K., Barbara Wexelman, Steven Chen, et al.. (2022). Home Recovery After Mastectomy: Review of Literature and Strategies for Implementation American Society of Breast Surgeons Working Group. Annals of Surgical Oncology. 29(9). 5799–5808. 15 indexed citations

Brenin, David R., Jill R. Dietz, Jennifer Baima, et al.. (2020). Pain Management in Breast Surgery: Recommendations of a Multidisciplinary Expert Panel—The American Society of Breast Surgeons. Annals of Surgical Oncology. 27(12). 4588–4602. 23 indexed citations

Rahimi, Asal, Osama Mohamad, Kevin Albuquerque, et al.. (2019). Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial. Supportive Care in Cancer. 28(3). 1481–1489. 9 indexed citations

Manahan, Michele A., William A. Wooden, Stephen M. Becker, et al.. (2017). Evidence-Based Performance Measures: Quality Metrics for the Care of Patients Undergoing Breast Reconstruction. Plastic & Reconstructive Surgery. 140(6). 775e–781e. 9 indexed citations

Thomas, K., Roshni Rao, Abu Minhajuddin, et al.. (2017). Constructing a Clinicopathologic Prognostic Model for Triple-Negative Breast Cancer. 13(1). 3 indexed citations

Rahimi, Asal, K. Thomas, Ann Spangler, et al.. (2017). Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation. International Journal of Radiation Oncology*Biology*Physics. 98(1). 196–205.e2. 49 indexed citations

10.

Rao, Roshni, Aeisha Rivers, Asal Rahimi, et al.. (2016). Genetic Ancestry using Mitochondrial DNA in patients with Triple‐negative breast cancer (GAMiT study). Cancer. 123(1). 107–113. 6 indexed citations

11.

Thomas, K., Asal Rahimi, Roshni Rao, et al.. (2016). Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients. Breast Cancer Research and Treatment. 161(3). 463–471. 31 indexed citations

12.

Sarode, Venetia, Alana Christie, Rebecca Collins, et al.. (2015). Evaluation of HER2/neu Status by Immunohistochemistry Using Computer-Based Image Analysis and Correlation With Gene Amplification by Fluorescence In Situ Hybridization Assay: A 10-Year Experience and Impact of Test Standardization on Concordance Rate. Archives of Pathology & Laboratory Medicine. 139(7). 922–928. 20 indexed citations

13.

Huth, James F., et al.. (2015). Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple‐negative breast cancer. Cancer Medicine. 4(4). 500–506. 13 indexed citations

14.

Lang, Julie E., Welela Tereffe, Melissa P. Mitchell, et al.. (2013). Primary Tumor Extirpation in Breast Cancer Patients Who Present with Stage IV Disease is Associated with Improved Survival. Annals of Surgical Oncology. 20(6). 1893–1899. 51 indexed citations

15.

Euhus, David, et al.. (2011). Evaluation of a hydrogel based breast biopsy marker (HydroMARK®) as an alternative to wire and radioactive seed localization for non‐palpable breast lesions. Journal of Surgical Oncology. 105(6). 591–594. 49 indexed citations

16.

Han, Jeong, Dengfeng Cao, Kyle Molberg, et al.. (2011). Hormone Receptor Status Rather Than HER2 Status Is Significantly Associated With Increased Ki-67 and p53 Expression in Triple-Negative Breast Carcinomas, and High Expression of Ki-67 but Not p53 Is Significantly Associated With Axillary Nodal Metastasis in Triple-Negative and High-Grade Non–Triple-Negative Breast Carcinomas. American Journal of Clinical Pathology. 135(2). 230–237. 27 indexed citations

17.

Bailey, Steven H., Michel Saint‐Cyr, Georgette Oni, et al.. (2011). Aesthetic Subunit of the Breast. Annals of Plastic Surgery. 68(3). 240–245. 12 indexed citations

18.

Sarode, Venetia, Jeong Han, Danielle H. Morris, Yan Peng, & Roshni Rao. (2011). A Comparative Analysis of Biomarker Expression and Molecular Subtypes of Pure Ductal Carcinoma In Situ and Invasive Breast Carcinoma by Image Analysis: Relationship of the Subtypes with Histologic Grade, Ki67, p53 Overexpression, and DNA Ploidy. International Journal of Breast Cancer. 2011. 1–7. 12 indexed citations

19.

Estroff, Jordan M., David Euhus, A. Marilyn Leitch, et al.. (2010). Delays in Time to Treatment and Survival Impact in Breast Cancer. Annals of Surgical Oncology. 17(S3). 291–296. 89 indexed citations

20.

Rao, Roshni, et al.. (1972). Treatment of early breast cancer.. BMJ. 2(5815). 711.1–712. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact